Council of the Federation negotiating with pharmaceutical suppliersAfter already negotiating bulk purchasing deals for six of the most commonly used generic drugs, the Council of the Federation (CoF) is now working on lowering prices for 27 brand-name drugs, as well. Alzheimer’s disease: Biomarker boondoggle?‘Biomarkers’ will be risk factors rather than definitive disease criteria: Canadian expert New function for old gene leads to possible kidney disease therapy TORONTO | Mount Sinai Hospital researchers may have found a way to slow the progression of kidney disease, one of the most serious complications for patients with diabetes. Psychiatry in the News - August 9, 2013 Thiessen releases report on cancer drug supply chain Pharmacist charged with reviewing Ontario’s chemotherapy under-dosing crisis unveils his findings State of Industry Report: Manitoba A snapshot of the pharmacy profession in Canada today Recommendations for long-acting injectable antipsychotics Proposals were developed to assist clinicians with the treatment of schizophrenia. State of Industry Report: P.E.I. A snapshot of the pharmacy profession in Canada today State of Industry Report: Quebec A snapshot of the pharmacy profession in Canada today State of Industry Report: British Columbia A snapshot of the pharmacy profession in Canada today First Previous 126 127 128 129 130 Next Last
